chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: 3 family members, all who had received the bivalent COVID vaccine, reported a positive COVID test.; 3 family members, all who had received the bivalent COVID vaccine, reported a positive COVID test.; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "3 family members, all who had received the bivalent COVID vaccine, reported a positive COVID test.". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: reported a positive COVID test. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: After a family gathering at the , 3 family members, all who had received the bivalent COVID vaccine, reported a positive COVID test. The two family members over the age of 50 have been prescribed Paxlovid. Event took place after use of product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201333384 same product and event, different patient;US-PFIZER INC-202201333385 same product and event, different patient;
Sex: U
Vaccine: COVID19
Symptoms: Eczema, Scratch, Wound haemorrhage
Clinical narrative: moderate to severe eczema; Scratching my legs until they bleed; Scratching my legs until they bleed; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for Covid-19 immunization; Bnt162b2 (DOSE 2, SINGLE), for Covid-19 immunization. The following information was reported: ECZEMA (non-serious), outcome "unknown", described as "moderate to severe eczema"; SCRATCH (non-serious), WOUND HEMORRHAGE (non-serious), outcome "unknown" and all described as "Scratching my legs until they bleed".  Additional information: All of my vaccines and boosters were Pfizer. I now have moderate to severe eczema, for the first time ever in my life. Scratching my legs until they bleed, thank you so much.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Sex: U
Vaccine: FLUX
Symptoms: Influenza
Clinical narrative: flu; Initial information received on 21-Nov-2022 regarding an unsolicited valid non-serious case received from a consumer/non-healthcare professional via social media.  This case involves a patient of unknown age and gender who developed flu after receiving Quadrivalent Influenza Vaccine (Influenza Vaccine (Quadrivalent)).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect Quadrivalent Influenza Vaccine (dose, strength, formulation, lot number, route, administration site and expiry date: not reported) for influenza.  On an unknown date the patient developed flu (influenza) (unknown latency) following the administration of Quadrivalent Influenza Vaccine.   Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event.
Sex: U
Vaccine: FLUX
Symptoms: Illness
Clinical narrative: got the flu shot but still got sick; Initial information received on 24-Nov-2022 regarding an unsolicited valid non-serious case received from a consumer via social media.   This case involves a patient of unknown age and unknown gender who reported got the flu shot but still got sick after receiving influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient had received an unknown dose of suspect influenza vaccine produced by unknown manufacturer (strength, route, formulation, batch number and expiry date: unknown) in unknown administration site for prophylactic vaccination.  On an unknown date, the patient reported got the flu shot but still got sick (illness) (latency: unknown) following the administration of influenza vaccine.  Lab tests were not reported.   Action taken: Not applicable.  It was not reported if the patient received a corrective treatment for the event (got the flu shot but still got sick).  At time of reporting, the outcome was unknown for the event.
Sex: U
Vaccine: FLUX
Symptoms: Illness, Malaise
Clinical narrative: still got sick very sick; Initial information received on 24-Nov-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves an unknown age and unknown gender patient who still got sick very sick after receiving vaccine influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received suspect influenza vaccine produced by unknown manufacturer (strength, dose, frequency, formulation, route, batch number, expiry date: unknown) in unknown administration site flu vaccination.  On an unknown date the patient diagnosed with a non-serious event of still got sick very sick (illness) (unknown latency) following the administration of influenza vaccine.  It was reported this case is received from Social media, The following potential adverse event has been found on a public post and I still got sick very sick.  No lab data was reported.  Action taken was unknown.  It was not reported if the patient received a corrective treatment for the event.  Outcome was Unknown.
Sex: U
Vaccine: FLUX
Symptoms: Influenza
Clinical narrative: flu; Initial information received on 24-Nov-2022 regarding an unsolicited valid Social Media non-serious case via consumer/non-healthcare professional.  This case involves an unknown age and unknown gender patient who had flu after receiving influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s), Concomitant(s) and family history were not provided.   On an unknown date, the patient received an unknown dose of suspect influenza vaccine produced by unknown manufacturer (strength, form, batch lot number, expiry date: Unknown) via unknown route in unknown administration site for Prophylactic vaccination. Information on batch lot number and expiry date was requested.  On an unknown date the patient had a non-serious event of flu (influenza) (unknown latency) following the administration of influenza vaccine.  Action taken with influenza vaccine was not applicable.  It was not reported if the patient received a corrective treatment for the event.  Outcome: Unknown.
Sex: U
Vaccine: FLUX
Symptoms: Illness
Clinical narrative: got sick; Initial information  was received on 24-Nov-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-HCP.  This case involves a patient with unknown demographics who got sick after being vaccinated with Influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect Influenza vaccine (produced by unknown manufacturer) (with unknown strength, dose, route, administration site, lot number and expiration date) for prophylactic vaccination.  On an unknown date the patient got sick (illness) (unknown latency) following the administration of Influenza vaccine.  Action taken: Not applicable.  Corrective treatment: Not reported.  Outcome: Unknown.
Sex: U
Vaccine: FLUX
Symptoms: Feeling abnormal
Clinical narrative: The last time I took a flu shot I almost died; Initial information received on 26-Nov-2022 regarding an unsolicited valid social media non-serious case received from a consumer/non-hcp (non-healthcare professional).  This case involves a patient of an unknown age and gender who reported the last time I took a flu shot I almost died after receiving influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received an unknown dose of suspect Influenza Vaccine produced by unknown manufacturer (with an unknown strength, formulation, administration site, lot number and expiry date ) for immunization.  On an unknown date, the patient reported last time he took a flu shot he almost died (Adverse event) (latency: unknown) following the administration of influenza vaccine.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event.  Outcome: Unknown.
Sex: M
Vaccine: FLUX
Symptoms: Influenza
Clinical narrative: My son did and now he has the flu; Initial information received on 26-Nov-2022 regarding an unsolicited valid  non-serious case received from a patient. This case involves an unknown age male patient who experienced my son did and now he has the flu after receiving vaccine INFLUENZA VACCINE.  It was unknown if the patient experienced any additional symptoms/events.  It was unknown if the patient had any medical history, concomitant disease or risk factor.   On an unknown date, the patient received a suspect INFLUENZA VACCINE produced by unknown manufacturer(strength, dose, formulation, frequency, lot number and expiry date: not reported) via unknown route in unknown administration site for Flu(Influenza).  On an unknown date the patient developed a non-serious event my son did and now he has the flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported Medication Details and reason for taking the medicine: Product name was not provided. Since this is a public post we are assuming the consumer is referring to the Sanofi flu vaccine.  It was unknown if there were lab data/results available.   Action taken : Not applicable.  It was not reported if the patient received a corrective treatment for the event (My son did and now he has the flu).  At time of reporting, the outcome was Unknown for the event my son did and now he has the flu.
Sex: M
Vaccine: FLUX
Symptoms: Influenza, Malaise
Clinical narrative: took shot in my grandson did to still got flu in still sick 17 days its been; Initial information was received on 27-Nov-2022 regarding an unsolicited valid Social Media non-serious case received from a non-health-care professional.  This case involves an unknown age male patient who had an event, "took shot in my grandson did to still got flu in still sick 17 days its been" after receiving vaccine influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect influenza vaccine produced by unknown manufacturer (strength, dose, formulation, frequency, lot number and expiry date: not reported) via unknown route in unknown administration site for Prophylactic vaccination (Immunisation).      On an unknown date the patient had a non-serious event of took shot in my grandson did to still got flu in still sick 17 days its been (influenza) (unknown latency) following the administration of influenza vaccine.  No lab data was reported.  Action taken with influenza vaccine was not applicable.  It was not reported if the patient received a corrective treatment.  Outcome: Unknown.
Sex: U
Vaccine: FLUX
Symptoms: Influenza
Clinical narrative: still got flu; Initial information was received on 26-Nov-2022 regarding an unsolicited valid Social Media non-serious case received from a patient  This case involves a patient with unknown demographics who still got flu after being vaccinated with Influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect Influenza vaccine (produced by unknown manufacturer) (with unknown strength, dose, route, administration site, lot number and expiration date) for prophylactic vaccination.  On an unknown date the patient still got flu (influenza) (unknown latency) following the administration of Influenza vaccine.  Action taken: Not applicable.  Corrective treatment: Not reported.  Outcome: Unknown.
Age: 14.0
Sex: F
Vaccine: FLUR3
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: given to a patient under 18 years of age with no reported adverse event; Initial information was received on 21-Nov-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 14 years old female patient who had given to a patient under 18 years of age with no reported adverse event after receiving influenza quadrivalent recombinant vaccine [Flublok].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. At the time of the event, the patient had ongoing Egg allergy.   On 19-Nov-2022, the patient received 0.5 ml dose of suspect influenza quadrivalent recombinant vaccine (unknown formulation) (Frequency: once) (with lot: UJ909AA, expiry date: 30-Jun-2023) (strength was unknown) via intramuscular route in left deltoid site for Immunization.  On 19-Nov-2022 the patient had a non-serious event given to a patient under 18 years of age with no reported adverse event (Product administered to patient of inappropriate age) (latency: same day) following the administration of influenza quadrivalent recombinant vaccine.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Recovered / Resolved in 2022 for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 1.0
Sex: M
Vaccine: HIBV
Symptoms: Accidental exposure to product, Medication error, No adverse event
Clinical narrative: needle bent upon injection and as a result the vaccine ran down the patient and he did not receive any of the dose, with no reported adverse event; Initial information received on 23-Nov-2022 regarding an unsolicited valid non-serious case received from other health professional.  This case involves a 1 years old male patient and it was reported that the needle bent upon injection and as a result the vaccine ran down the patient and he did not receive any of the dose, with no reported adverse event while receiving HIB (PRP/T) vaccine [ACT-HIB].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (Daptacel); and pneumococcal vaccine conj 7V (CRM197) (Prevnar).  On 21-Nov-2022, the patient received a 0.5 ml dose of suspect HIB (PRP/T) vaccine powder and solvent for solution for injection with lot number- UJ646AAA and expiry date: 05-Mar-2023 (strength: unknown) via intramuscular route in the right thigh for prophylactic vaccination.   On 21-Nov-2022, the needle bent upon injection and as a result the vaccine ran down the patient and he did not receive any of the dose, with no reported adverse event (Inadvertent exposure to vaccine) (latency: same day) following the administration of HIB (PRP/T) vaccine.  Lab tests were not reported.  Action taken: Not applicable.  At time of reporting, the outcome was unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 40.0
Sex: M
Vaccine: UNK
Symptoms: Arthralgia, Immediate post-injection reaction, Joint range of motion decreased, Magnetic resonance imaging abnormal, Product administered at inappropriate site
Clinical narrative: Pt reports vaccine administration more superiorly in the shoulder than expected. Had immediate pain in the shoulder and approx 2 weeks later developed decreased ROM and pulling sensation in the shoulder
Age: 40.0
Sex: M
Vaccine: UNK
Symptoms: Sensory disturbance, Tendonitis
Clinical narrative: Pt reports vaccine administration more superiorly in the shoulder than expected. Had immediate pain in the shoulder and approx 2 weeks later developed decreased ROM and pulling sensation in the shoulder
Age: 4.0
Sex: F
Vaccine: MMRV
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AE.; an improperly stored vaccine was administered to a patient PROQUAD (Lot: U029319)/PROQUAD (Lot: W024548); This spontaneous report was received from a registered nurse and refers to a 4-year-old female patient. The patient's medical history included haemangioma. The patient was also a premature newborn (31 weeks, 1480 g birth weight). Her concurrent conditions included dysuria. Concomitant medications included diphtheria vaccine toxoid (+) pertussis vaccine acellular 3-component (+) polio vaccine inact 3v (vero) (+) tetanus vaccine toxoid (KINRIX) and influenza vaccine (manufacturer reported as GSK).   On 12-OCT-2022 the patient was vaccinated with of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) 0.5 ml, lot number W024548, expiration date: 31-JAN-2024, administered subcutaneously in the right vastus lateralis for prophylaxis. Before the administration, the vaccine underwent temperature excursion of 10.8 degrees Fahrenheit for 18 hours 30 minutes (product storage error). There was no previous temperature excursion. There was no adverse event reported (no adverse event).  This is one of several reports from the same reporter.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Incomplete course of vaccination, Pain
Clinical narrative: Pain, aches; 1st shot almost a year ago, never got the 2nd shot; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient did not receive the 2nd dose of Shingles vaccine and received the 1st dose of Shingles vaccine. On an unknown date, not applicable after receiving Shingles vaccine and less than a year after receiving Shingles vaccine, the patient experienced pain and incomplete course of vaccination. On an unknown date, the outcome of the pain was recovered/resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 21-NOV-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient received first dose of Shingles vaccine almost a year ago and the side effects were pain, aches which lasted a couple of days so the patient never got the second shot of Shingles vaccine. The reporter asked do he/she get any protection from the first shot of Shingles vaccine. Additional Supportive Information: Till the time of reporting, the patient did not receive 2nd dose of Shingles vaccine, which led to incomplete course of vaccination. Follow-up would not possible as no contact details were available.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: FELT TIRED; SLIGHT HEADACHE; This spontaneous report received from a patient concerned a female of an unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin not reported, batch number: 1805022 and expiry: UNKNOWN) dose was not reported, 1 total, dose 1 (first dose) administered in left arm on 25-MAR-2021 for covid-19 prophylaxis. No concomitant medications were reported. On 25-MAR-2021, the patient experienced slight headache (Dose number in series 1). On 26-MAR-2021, the patient experienced felt tired and she rested for the day (Dose number in series 1). The patient additionally received booster dose of covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin and batch number were not reported, expiry: Unknown) dose was not reported, 1 total, dose 2 (second dose) administered on 23-DEC-2021 for covid-19 prophylaxis.  No adverse events were reported following vaccination with booster dose of covid-19 vaccine ad26.cov2.s (Dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the slight headache and felt tired was not reported. This report was non-serious.
Sex: U
Vaccine: FLUX
Symptoms: Influenza
Clinical narrative: got the flu; Initial information received on 23-Nov-2022 regarding an unsolicited valid social media non-serious case received via consumer/non-hcp.  This case involves patient of unknown demographics who experienced got the flu while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received suspect INFLUENZA VACCINE produced by unknown manufacturer at (unknown: formulation, strength, dose, lot number, route in unknown administration site) for prophylactic vaccination. Information regarding batch number requested.  On an unknown date, the patient developed a non-serious got the flu (influenza) at unknown latency following the administration of INFLUENZA VACCINE.  It was reported that "got my flu shot and still got the flu. Since this was a public post on the Sanofi flu shot campaign we are assuming the consumer is referring to the Sanofi flu vaccine."   Action taken: Not applicable.  It was not reported if the patient received a corrective treatment for the event (got the flu).  At time of reporting, the outcome was Unknown for the event got the flu.
Sex: U
Vaccine: FLUX
Symptoms: Influenza
Clinical narrative: got the Flu.; Initial information received  on 26-Nov-2022 regarding an unsolicited valid non-serious case from a consumer/non-health care professional.  This case involves an unknown age and unknown gender patient who  got the flu after receiving vaccine Influenza Vaccine.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided.   On an unknown date, the patient vaccinated with a dose of suspect influenza vaccine produced by unknown manufacturer (strength, formulation, frequency, dosage, lot number, and expiry date: not reported) via unknown route in unknown administration site for prophylactic vaccination and got the flu (influenza) (unknown latency).  No lab data was reported.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event.   The outcome was Unknown.
Age: 7.0
Sex: F
Vaccine: DTAPIPV
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: a child was administered Quadracel after they had turned 7 years of age with no reported adverse event; Initial information received on 23-Nov-2022 regarding an unsolicited valid  non-serious case received from  other health professional.  This case involves a 7 years old female patient who was administered diphtheria-15/tetanus/5 hybrid AC pertussis/IPV (MRC5) vaccine [Quadracel] after they had turned 7 years of age with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included hepatitis A vaccine inact (Havrix) for Immunisation.  On 21-Nov-2022, the patient received 0.5 mL total dose of suspect diphtheria-15/tetanus/5 hybrid AC pertussis/IPV (MRC5) vaccine (formulation and strength not reported; lot U75268A and expiry date: 07-Sep-2024) via intramuscular route in unknown administration site for prophylactic immunization.  On 21-Nov-2022, the patient who was a child was administered quadracel after they had turned 7 years of age with no reported adverse event (product administered to patient of inappropriate age) (latency: same day).  It was reported, a child was administered QUADRACEL after they had turned 7 years of age. This situation is reported as a medication error due to the patient not being in the age range of 4-6 years as stated on the label.  Action taken was not applicable.  At time of reporting, the outcome was Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 64.0
Sex: F
Vaccine: COVID19-2
Symptoms: Induration, Lip swelling, Sensory disturbance
Clinical narrative: SWOLLEN LIPS, different areas of lips at different times of occurrences. Lips will stay swollen for2-3 days at different degrees,reoccurrence  4-5 days from from last occurrence.Lips feel thick , firm to touch. I?ve taken an antihistamine , which decreases the swelling somewhat, but comes back.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Wrong product administered
Clinical narrative: The patient came in for a Novavax vaccine as a booster after Janssen initial vaccine.  He  refused to get an mRNA vaccine.   He was given the Janssen vaccine instead of Novavax.  He has not reported any adverse events at this time.
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Error: Wrong Dose of Vaccine - Too Low-
Age: 63.0
Sex: F
Vaccine: FLU4
Symptoms: Pruritus, Rash
Clinical narrative: Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Additional Details: pt developed itch and rash around neck 10-15 min after shot. Hasnt had flu shot in 20 years, 50mg benadryl given, Emergency called. Pt had no other symptoms. vitals were checked by emt, and pt was advised to go to urgent care if needed. oxygen saturation 98%. pt went home with family.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: The patient came in to get a Novavax vaccination and was given a Janssen vaccine instead.  This was a booster dose and she did not want an mRNA vaccine.  Pharmacist pulled the Janssen instead of the Novavax.
Age: 16.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dizziness, Syncope
Clinical narrative: Systemic: Fainting / Unresponsive-Mild, Additional Details: pt felt dizzt and fainted a few minutes after shot. watched the pt about 15 minutes and thet recovered fine and told me she was feeling better
Age: 41.0
Sex: M
Vaccine: COVID19-2
Symptoms: Dizziness, Fall
Clinical narrative: Systemic: Dizziness / Lightheadness-Mild, Additional Details: Pt felt lightheadness, fell slightly on ground (did not injury head).pt did not pass out/loss consciousness. pt rested with legs ups on chair for 15 mins. Ambulance came just in case to check on pt. vital signs were checked. Pt given ok from ambulance - pt stable.pt provided water and chocolate for energy. Pt started to feel better was monitored for 20 mins more then pt went home. follow up call was made later that day around 7p. Pt stated was feeling much better. No further issues. Pt healthy.
Age: 98.0
Sex: M
Vaccine: COVID19
Symptoms: Bell's palsy
Clinical narrative: Bells Palsy Narrative:  5 days post vaccine Patient developed Bells Palsy, treated at ER, stroke r/o.
Age: 19.0
Sex: M
Vaccine: COVID19-2
Symptoms: Loss of consciousness, Pallor, Vomiting
Clinical narrative: Systemic: Vomiting-Mild, Additional Details: patient passed out for about a minute, vomitting, pale looking, was able to wake up right away, was instructed to take deep breath, drink some water, was obsered for 15 minutes then sit up for 10 minutes before walk away.
Age: 56.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Error: Wrong Vaccine/Product Administered-
Age: 28.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Error: Wrong Vaccine Formulation (ex. Prevnar 13 v. Prevnar 23)-
Age: 45.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient came in for a Pfizer first vaccination. (Primary Immunization). She was given a Pfizer Bivalent Booster instead of the Pfizer primary vaccination.  Not aware of any adverse symptoms at this time.
Age: 41.0
Sex: F
Vaccine: COVID19-2
Symptoms: Basedow's disease, Blood thyroid stimulating hormone, Full blood count, Influenza virus test, Liver function test
Clinical narrative: Severe heart palpitations, weight loss, and a recent diagnosis of Graves Disease.  Starting methimicil and currently on atenolol.  No symptoms prior to vaccine.  Thyroid was checked a year or so ago and was fine.
Age: 41.0
Sex: F
Vaccine: COVID19-2
Symptoms: Metabolic function test, Palpitations, Respiratory syncytial virus test, SARS-CoV-2 test, Thyroid function test
Clinical narrative: Severe heart palpitations, weight loss, and a recent diagnosis of Graves Disease.  Starting methimicil and currently on atenolol.  No symptoms prior to vaccine.  Thyroid was checked a year or so ago and was fine.
Age: 41.0
Sex: F
Vaccine: COVID19-2
Symptoms: Thyroxine, Ultrasound thyroid, Weight decreased
Clinical narrative: Severe heart palpitations, weight loss, and a recent diagnosis of Graves Disease.  Starting methimicil and currently on atenolol.  No symptoms prior to vaccine.  Thyroid was checked a year or so ago and was fine.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Multisystem inflammatory syndrome
Clinical narrative: Multisystem Inflammatory Syndromw
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Abortion spontaneous, Maternal exposure before pregnancy
Clinical narrative: Miscarriage
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid vaccine breakthrough case  dose 1 Moderna 2/13/21 031M20A dose 2 Moderna 3/13/21 040A21A dose 3 Moderna 11/11/21 039F21A
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Myalgia
Clinical narrative: Brain fog, muscle aches, fatigue
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid vaccine breakthrough case  dose 1 Moderna 4/21/21 025B21A dose 2 Moderna 5/20/21 041C21A
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid vaccine breakthrough case   dose 1 Moderna 4/28/21  005C21A dose 2 Moderna 5/26/21 041C21A
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid vaccine breakthrough case
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid vaccine breakthrough case   dose 1 3/3/21 Pfizer EN6202 dose 2 3/24/21 Pfizer EN6207
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Injection site pain, Lethargy
Clinical narrative: Day 1 Sore inj site, day 2 H/a and lethargy Narrative:
Age: 54.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blood thyroid stimulating hormone normal, Chills, Electrocardiogram normal, Fibrin D dimer normal, Full blood count normal
Clinical narrative: 11/28/22, Chills approx. 9:00 pm 11/29/22, Approx. 2:00 am.   I woke up with headaches & tachycardia.  Heart Racing continued & I went to hospital for treatment.
Age: 54.0
Sex: F
Vaccine: COVID19-2
Symptoms: Headache, Laboratory test normal, Metabolic function test normal, Palpitations, Sleep disorder
Clinical narrative: 11/28/22, Chills approx. 9:00 pm 11/29/22, Approx. 2:00 am.   I woke up with headaches & tachycardia.  Heart Racing continued & I went to hospital for treatment.
Age: 54.0
Sex: F
Vaccine: COVID19-2
Symptoms: Tachycardia, Troponin
Clinical narrative: 11/28/22, Chills approx. 9:00 pm 11/29/22, Approx. 2:00 am.   I woke up with headaches & tachycardia.  Heart Racing continued & I went to hospital for treatment.
Age: 72.0
Sex: F
Vaccine: FLUA4
Symptoms: Amnesia, Dizziness, Eye movement disorder, Fall, Unresponsive to stimuli
Clinical narrative: Approximately 5-10 minutes after vaccine administration patient fell in the waiting area of the pharmacy while pushing shopping cart away from area.  She was with her husband who was having difficulty ambulating so we are unsure if she lost her footing (she does have history of falls) or if she had episode of syncope. Bystanders said it looked like she just fell straight back, possibly shopping cart moved faster than she was moving her feet. When I got to her she was laying on her back on the floor - her eyes were slightly rolled back in her head, her mouth was open and it was almost like she was choking. After watching her she was breathing but she could not respond to my questions. We called 911 and within a few minutes she came around and was able to answer questions. She didn't have any memory of falling but said she might have felt a little lightheaded right before falling.
Age: 65.0
Sex: M
Vaccine: COVID19-2
Symptoms: Fatigue, Sluggishness
Clinical narrative: Fatigue and sluggishness
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain, COVID-19, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: 09/27/22 presents to ED for "fever" "some abdominal cramping". PMHx of "metastatic leiomyosarcoma"
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Cough, Headache, SARS-CoV-2 test positive, Vomiting
Clinical narrative: 09/22/22 presents to ED for "headache, vomiting, cough". PMHx of "HTN"
Age: 57.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event
Clinical narrative: No adverse events have been reported at this time. Patient tolerated vaccine in clinic without complications.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Eye discharge, Eye pain, Periorbital oedema, SARS-CoV-2 test positive
Clinical narrative: Vaccinated pt admitted to inpatient facility with positive covid test results. No information available concerning vaccination including manufacturer, date, etc. Vaccination  status was reported by patient.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Visual impairment
Clinical narrative: Vaccinated pt admitted to inpatient facility with positive covid test results. No information available concerning vaccination including manufacturer, date, etc. Vaccination  status was reported by patient.
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: 09/22/22 reports to ED for "shortness of breath". PMHx of "HTN, dementia, DM"
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient is an inmate at the local jail. Patient signed consent form and indicated on consent form that he had never received a covid vaccine. Consents were reveiwed in office and patient only had 1 previous covid vaccine in the system. Patient was given dose of Moderna as a 2nd dose. When the vaccine administered went to patients record, the patient had received a 2nd dose of Moderna bivalent previously.
Age: 85.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dyspnoea
Clinical narrative: 09/22/22 presents to ED for "shortness of breath". PMHx of "asthma, hypertension and hypothyroid"
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalized with covid; fully vaccinated with booster
Age: 87.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event
Clinical narrative: None noted at this time. Patient tolerated vaccine administered in clinic without complications.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalized with covid; fully vaccinated with booster
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Hospitalized with COVID 19
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, COVID-19, Micturition urgency, Nausea, Pollakiuria
Clinical narrative: 09/22/22 presents to EC ED for "right-sided abdominal pain with associated, urinary frequency, urgency, nausea and vomiting". PMHx of "hypertension, migraines, CAD with stents, asthma, frequent UTIs, osteoporosis, osteoarthritis and chronic pain"
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Vomiting
Clinical narrative: 09/22/22 presents to EC ED for "right-sided abdominal pain with associated, urinary frequency, urgency, nausea and vomiting". PMHx of "hypertension, migraines, CAD with stents, asthma, frequent UTIs, osteoporosis, osteoarthritis and chronic pain"
Age: 69.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalized with covid; fully vaccinated with 2 boosters
Age: 10.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient was supposed to receive his second monovalent Pfizer vaccine. He was given the Bivalent Pfizer vaccine instead.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against then tested positive for COVID-19
Age: 19.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against then tested positive for COVID-19
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Monovalent Booster given instead of Bivalent Booster there have been no adverse reaction at all
Age: 9.0
Sex: M
Vaccine: COVID19-2
Symptoms: Abdominal pain, Chest pain, Cough, Electrocardiogram normal, Headache
Clinical narrative: Cough, abdominal pain, sore throat, chest pain, headache, nasal and chest congestion
Age: 9.0
Sex: M
Vaccine: COVID19-2
Symptoms: Influenza A virus test positive, Nasal congestion, Oropharyngeal pain, Respiratory tract congestion, SARS-CoV-2 test negative
Clinical narrative: Cough, abdominal pain, sore throat, chest pain, headache, nasal and chest congestion
Age: 9.0
Sex: M
Vaccine: COVID19-2
Symptoms: Streptococcus test negative
Clinical narrative: Cough, abdominal pain, sore throat, chest pain, headache, nasal and chest congestion
Age: 58.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalized with covid; fully vaccinated with 3 boosters
Age: 12.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Patient received one dose and should have received adult dose of bivalent. No adverse reaction
Age: 82.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Acute kidney injury, Acute respiratory failure, Anticoagulant therapy, Anuria, COVID-19
Clinical narrative: Discharge Provider: DO Primary Care Physician at Discharge: MD   Admission Date: 11/18/2022 COVID positive Date 11/18/2022 Date of Death: 11/23/22 Time of Death: 11:21 AM PRESENTING PROBLEM: Acute respiratory failure with hypoxia  [J96.01] Multifocal pneumonia [J18.9] Acute on chronic congestive heart failure, unspecified heart failure type [I50.9]   HOSPITAL COURSE: Patient is an 82 y/o male with CAD, chronic systolic and diastolic CHF and stage IV CKD who presented with syncope.  It was unclear on presentation whether this was due to cardiac vs. neurologic cause. Work-up revealed bilateral CVAs as well as acute CHF with elevated troponin. He was noted to be COVID positive, but family reported that he had symptoms and positive test 2 weeks prior.  Neurology and cardiology were consulted, echo was ordered, lasix was started. Echo showed new EF reduction. Neurology started apixaban and stopped ASA as well as plavix. He was started on IV Lasix, and doses were increased due to poor response. With increasing dose of Lasix, he continued to have low urine output and developed acute kidney injury with hyperphosphatemia, increased edema and hypoxia.  By 11/22, he was essentially anuric. Nephro was consulted and felt dialysis could be considered should his renal function continue to worsen and volume status not improve with diuresis.  This was discussed with patient and family, and patient was clear that he did not wish to proceed with dialysis.  He underwent right heart cath on 11/22, which showed elevated PCWP and borderline low cardiac index, for which continued diuresis/fluid removal was recommended.  He had continued worsening of his respiratory status in the early morning of 11/23, requiring high flow nasal cannula.  After further discussions with family, decision was made to proceed with comfort care.  Hospice was consulted, and comfort measures were instituted with prn Ativan and Fentanyl drip.  He expired on 11/23/22 at 11:21 AM.
Age: 82.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Cardiac failure acute, Cardiac failure congestive, Cardiac index decreased, Catheterisation cardiac abnormal, Cerebrovascular accident
Clinical narrative: Discharge Provider: DO Primary Care Physician at Discharge: MD   Admission Date: 11/18/2022 COVID positive Date 11/18/2022 Date of Death: 11/23/22 Time of Death: 11:21 AM PRESENTING PROBLEM: Acute respiratory failure with hypoxia  [J96.01] Multifocal pneumonia [J18.9] Acute on chronic congestive heart failure, unspecified heart failure type [I50.9]   HOSPITAL COURSE: Patient is an 82 y/o male with CAD, chronic systolic and diastolic CHF and stage IV CKD who presented with syncope.  It was unclear on presentation whether this was due to cardiac vs. neurologic cause. Work-up revealed bilateral CVAs as well as acute CHF with elevated troponin. He was noted to be COVID positive, but family reported that he had symptoms and positive test 2 weeks prior.  Neurology and cardiology were consulted, echo was ordered, lasix was started. Echo showed new EF reduction. Neurology started apixaban and stopped ASA as well as plavix. He was started on IV Lasix, and doses were increased due to poor response. With increasing dose of Lasix, he continued to have low urine output and developed acute kidney injury with hyperphosphatemia, increased edema and hypoxia.  By 11/22, he was essentially anuric. Nephro was consulted and felt dialysis could be considered should his renal function continue to worsen and volume status not improve with diuresis.  This was discussed with patient and family, and patient was clear that he did not wish to proceed with dialysis.  He underwent right heart cath on 11/22, which showed elevated PCWP and borderline low cardiac index, for which continued diuresis/fluid removal was recommended.  He had continued worsening of his respiratory status in the early morning of 11/23, requiring high flow nasal cannula.  After further discussions with family, decision was made to proceed with comfort care.  Hospice was consulted, and comfort measures were instituted with prn Ativan and Fentanyl drip.  He expired on 11/23/22 at 11:21 AM.
Age: 82.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Condition aggravated, Death, Echocardiogram abnormal, Ejection fraction decreased, Hyperphosphataemia
Clinical narrative: Discharge Provider: DO Primary Care Physician at Discharge: MD   Admission Date: 11/18/2022 COVID positive Date 11/18/2022 Date of Death: 11/23/22 Time of Death: 11:21 AM PRESENTING PROBLEM: Acute respiratory failure with hypoxia  [J96.01] Multifocal pneumonia [J18.9] Acute on chronic congestive heart failure, unspecified heart failure type [I50.9]   HOSPITAL COURSE: Patient is an 82 y/o male with CAD, chronic systolic and diastolic CHF and stage IV CKD who presented with syncope.  It was unclear on presentation whether this was due to cardiac vs. neurologic cause. Work-up revealed bilateral CVAs as well as acute CHF with elevated troponin. He was noted to be COVID positive, but family reported that he had symptoms and positive test 2 weeks prior.  Neurology and cardiology were consulted, echo was ordered, lasix was started. Echo showed new EF reduction. Neurology started apixaban and stopped ASA as well as plavix. He was started on IV Lasix, and doses were increased due to poor response. With increasing dose of Lasix, he continued to have low urine output and developed acute kidney injury with hyperphosphatemia, increased edema and hypoxia.  By 11/22, he was essentially anuric. Nephro was consulted and felt dialysis could be considered should his renal function continue to worsen and volume status not improve with diuresis.  This was discussed with patient and family, and patient was clear that he did not wish to proceed with dialysis.  He underwent right heart cath on 11/22, which showed elevated PCWP and borderline low cardiac index, for which continued diuresis/fluid removal was recommended.  He had continued worsening of his respiratory status in the early morning of 11/23, requiring high flow nasal cannula.  After further discussions with family, decision was made to proceed with comfort care.  Hospice was consulted, and comfort measures were instituted with prn Ativan and Fentanyl drip.  He expired on 11/23/22 at 11:21 AM.